In coming years, recently completed trials will be incorporated into current diabetes-treatment guidelines, and additional studies will address increasingly specific patient populations such as those with diabetes and CKD as well as those with heart failure and reduced ejection fraction
It allows for a truly personalized approach to medicine, where treatment can be tailored not just to a diagnosis, but to a patient's most important personal health goals
The result can be used as a starting point for setting a calorie target for weight maintenance, weight loss, or weight gain
This weight loss injection is a dual incretin agonist that simultaneously targets GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors
The Mechanism: Why One Drug Affects So Many Others GLP-1 drugs work partly by slowing gastric emptying food (and anything swallowed with it) sits in your stomach longer, which is part of why you feel full sooner